| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Thrombus aspiration during ST-segment elevation myocardial infarction.
|
N Engl J Med
|
2013
|
8.13
|
|
2
|
Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis.
|
JAMA
|
2008
|
3.12
|
|
3
|
Distribution of coronary artery stenosis after radiation for breast cancer.
|
J Clin Oncol
|
2011
|
2.71
|
|
4
|
N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease.
|
J Am Coll Cardiol
|
2003
|
2.36
|
|
5
|
The Swedish Web-system for enhancement and development of evidence-based care in heart disease evaluated according to recommended therapies (SWEDEHEART).
|
Heart
|
2010
|
2.24
|
|
6
|
Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data.
|
J Am Coll Cardiol
|
2010
|
2.17
|
|
7
|
Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome.
|
J Am Coll Cardiol
|
2009
|
1.71
|
|
8
|
Unfractionated heparin administration in patients treated with bivalirudin during primary percutaneous coronary intervention is associated lower mortality and target lesion thrombosis: a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).
|
Heart
|
2011
|
1.63
|
|
9
|
Persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome predicts long-term mortality.
|
Circulation
|
2007
|
1.61
|
|
10
|
Duration of dual antiplatelet treatment with clopidogrel and aspirin in patients with acute coronary syndrome.
|
Eur Heart J
|
2013
|
1.55
|
|
11
|
Effects of age on long-term outcomes after a routine invasive or selective invasive strategy in patients presenting with non-ST segment elevation acute coronary syndromes: a collaborative analysis of individual data from the FRISC II - ICTUS - RITA-3 (FIR) trials.
|
Heart
|
2011
|
1.55
|
|
12
|
Safety and efficacy of drug-eluting vs. bare metal stents in patients with diabetes mellitus: long-term follow-up in the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).
|
Eur Heart J
|
2009
|
1.55
|
|
13
|
Clinical and analytical performance of the liaison cardiac troponin I assay in unstable coronary artery disease, and the impact of age on the definition of reference limits. A FRISC-II substudy.
|
Clin Chem
|
2003
|
1.54
|
|
14
|
Lower risk of stent thrombosis and restenosis with unrestricted use of 'new-generation' drug-eluting stents: a report from the nationwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR).
|
Eur Heart J
|
2012
|
1.50
|
|
15
|
Long-term mortality after PCI in patients with diabetes mellitus: results from the Swedish Coronary Angiography and Angioplasty Registry.
|
EuroIntervention
|
2010
|
1.45
|
|
16
|
Eptifibatide is noninferior to abciximab in primary percutaneous coronary intervention: results from the SCAAR (Swedish Coronary Angiography and Angioplasty Registry).
|
J Am Coll Cardiol
|
2010
|
1.44
|
|
17
|
Growth differentiation factor 15 for risk stratification and selection of an invasive treatment strategy in non ST-elevation acute coronary syndrome.
|
Circulation
|
2007
|
1.41
|
|
18
|
Long-term safety and efficacy of drug-eluting versus bare-metal stents in Sweden.
|
N Engl J Med
|
2009
|
1.41
|
|
19
|
Long-term cardiovascular mortality after procedure-related or spontaneous myocardial infarction in patients with non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II, ICTUS, and RITA-3 trials (FIR).
|
Circulation
|
2011
|
1.40
|
|
20
|
Effects of an early invasive strategy on ischemia and exercise tolerance among patients with unstable coronary artery disease.
|
Am J Med
|
2003
|
1.38
|
|
21
|
Are we using cardiovascular medications and coronary angiography appropriately in men and women with chest pain?
|
Eur Heart J
|
2011
|
1.36
|
|
22
|
Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization.
|
J Am Coll Cardiol
|
2004
|
1.24
|
|
23
|
Thrombus Aspiration in ST-Elevation myocardial infarction in Scandinavia (TASTE trial). A multicenter, prospective, randomized, controlled clinical registry trial based on the Swedish angiography and angioplasty registry (SCAAR) platform. Study design and rationale.
|
Am Heart J
|
2010
|
1.22
|
|
24
|
Evidence for obesity paradox in patients with acute coronary syndromes: a report from the Swedish Coronary Angiography and Angioplasty Registry.
|
Eur Heart J
|
2012
|
1.17
|
|
25
|
Effect of stent inflation pressure and post-dilatation on the outcome of coronary artery intervention. A report of more than 90,000 stent implantations.
|
PLoS One
|
2013
|
1.17
|
|
26
|
Outcome of percutaneous coronary intervention in hospitals with and without on-site cardiac surgery standby.
|
Heart
|
2006
|
1.16
|
|
27
|
Comparison of two drug-eluting balloons: a report from the SCAAR registry.
|
EuroIntervention
|
2012
|
1.12
|
|
28
|
Early angiography in patients with chronic kidney disease: a collaborative systematic review.
|
Clin J Am Soc Nephrol
|
2009
|
1.07
|
|
29
|
Improved identification of patients with coronary artery disease by the use of new lipid and lipoprotein biomarkers.
|
Am J Cardiol
|
2006
|
1.02
|
|
30
|
Clinical impact of second-generation everolimus-eluting stent compared with first-generation drug-eluting stents in diabetes mellitus patients: insights from a nationwide coronary intervention register.
|
JACC Cardiovasc Interv
|
2012
|
1.02
|
|
31
|
Incidence and predictors of coronary stent thrombosis: evidence from an international collaborative meta-analysis including 30 studies, 221,066 patients, and 4276 thromboses.
|
Int J Cardiol
|
2012
|
1.01
|
|
32
|
Gender perspective on risk factors, coronary lesions and long-term outcome in young patients with ST-elevation myocardial infarction.
|
Heart
|
2010
|
1.00
|
|
33
|
Differences in restenosis rate with different drug-eluting stents in patients with and without diabetes mellitus: a report from the SCAAR (Swedish Angiography and Angioplasty Registry).
|
J Am Coll Cardiol
|
2009
|
0.96
|
|
34
|
Growth-differentiation factor-15 for long-term risk prediction in patients stabilized after an episode of non-ST-segment-elevation acute coronary syndrome.
|
Circ Cardiovasc Genet
|
2009
|
0.95
|
|
35
|
Effect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
|
Eur Heart J
|
2011
|
0.94
|
|
36
|
Genetic variations in the tissue factor gene are associated with clinical outcome in acute coronary syndrome and expression levels in human monocytes.
|
Arterioscler Thromb Vasc Biol
|
2005
|
0.92
|
|
37
|
Initial clinical experience with an everolimus eluting platinum chromium stent (Promus Element) in unselected patients from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).
|
Int J Cardiol
|
2012
|
0.91
|
|
38
|
The prognostic and therapeutic implications of increased troponin T levels and ST depression in unstable coronary artery disease: the FRISC II invasive troponin T electrocardiogram substudy.
|
Am Heart J
|
2002
|
0.89
|
|
39
|
Population trends in percutaneous coronary intervention: 20-year results from the SCAAR (Swedish Coronary Angiography and Angioplasty Registry).
|
J Am Coll Cardiol
|
2013
|
0.89
|
|
40
|
Timing of angiography with a routine invasive strategy and long-term outcomes in non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II (Fragmin and Fast Revascularization During Instability in Coronary Artery Disease), ICTUS (Invasive Versus Conservative Treatment in Unstable Coronary Syndromes), and RITA-3 (Intervention Versus Conservative Treatment Strategy in Patients With Unstable Angina or Non-ST Elevation Myocardial Infarction) Trials.
|
JACC Cardiovasc Interv
|
2012
|
0.87
|
|
41
|
Outcome of drug-eluting versus bare-metal stenting used according to on- and off-label criteria.
|
J Am Coll Cardiol
|
2009
|
0.86
|
|
42
|
The 2011 outcome from the Swedish Health Care Registry on Heart Disease (SWEDEHEART).
|
Scand Cardiovasc J
|
2013
|
0.86
|
|
43
|
Delay from first medical contact to primary PCI and all-cause mortality: a nationwide study of patients with ST-elevation myocardial infarction.
|
J Am Heart Assoc
|
2014
|
0.85
|
|
44
|
Current treatment and outcome of coronary in-stent restenosis in Sweden: a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).
|
EuroIntervention
|
2013
|
0.84
|
|
45
|
An invasive or conservative strategy in patients with diabetes mellitus and non-ST-segment elevation acute coronary syndromes: a collaborative meta-analysis of randomized trials.
|
J Am Coll Cardiol
|
2012
|
0.83
|
|
46
|
Cardiovascular risk factors for stable angina pectoris versus unheralded myocardial infarction.
|
Am Heart J
|
2004
|
0.82
|
|
47
|
Oxidized low-density lipoprotein as a predictor of outcome in patients with unstable coronary artery disease.
|
Int J Cardiol
|
2005
|
0.82
|
|
48
|
Early invasive treatment benefits patients with renal dysfunction in unstable coronary artery disease.
|
Am Heart J
|
2006
|
0.82
|
|
49
|
Pathophysiologic mechanisms of persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome.
|
Am Heart J
|
2008
|
0.82
|
|
50
|
Usefulness of the admission electrocardiogram to predict long-term outcomes after non-ST-elevation acute coronary syndrome (from the FRISC II, ICTUS, and RITA-3 [FIR] Trials).
|
Am J Cardiol
|
2011
|
0.81
|
|
51
|
Quantitative analysis of the admission electrocardiogram identifies patients with unstable coronary artery disease who benefit the most from early invasive treatment.
|
J Am Coll Cardiol
|
2003
|
0.80
|
|
52
|
Efficacy and safety of clopidogrel after PCI with stenting in patients on oral anticoagulants with acute coronary syndrome.
|
EuroIntervention
|
2011
|
0.79
|
|
53
|
Outcome after percutaneous coronary intervention for different indications: long-term results from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).
|
EuroIntervention
|
2016
|
0.79
|
|
54
|
The impact of hypertension and diabetes on outcome in patients undergoing percutaneous coronary intervention.
|
Am J Med
|
2011
|
0.78
|
|
55
|
The relation of QT dispersion and localized QT difference to coronary pathology in a population with unstable coronary artery disease.
|
Ann Noninvasive Electrocardiol
|
2003
|
0.78
|
|
56
|
Cardiovascular registries: a novel platform for randomised clinical trials.
|
Heart
|
2012
|
0.78
|
|
57
|
Thrombus aspiration in ST-elevation myocardial infarction in Sweden: a short report on real world outcome.
|
Int J Cardiol
|
2010
|
0.78
|
|
58
|
Proximal coronary artery intervention: stent thrombosis, restenosis and death.
|
Int J Cardiol
|
2013
|
0.78
|
|
59
|
Patent coronary artery and myocardial infarction in the era of primary angioplasty: assessment of an old problem in a new setting with data from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).
|
EuroIntervention
|
2010
|
0.77
|
|
60
|
Coronary angiography of patients with a previous coronary artery by-pass operation is associated with a three times increased risk for neurological complications. A report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).
|
Scand Cardiovasc J
|
2009
|
0.75
|
|
61
|
The SCAAR-scare in perspective.
|
EuroIntervention
|
2009
|
0.75
|
|
62
|
Relationship between clopidogrel-induced platelet P2Y12 inhibition and stent thrombosis or myocardial infarction after percutaneous coronary intervention-a case-control study.
|
Am Heart J
|
2011
|
0.75
|
|
63
|
[Contrast medica nephropathy. Better understanding of risk markers and follow up needed].
|
Lakartidningen
|
2009
|
0.75
|
|
64
|
Outcome of percutaneous coronary intervention with the Absorb bioresorbable scaffold: data from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).
|
EuroIntervention
|
2017
|
0.75
|
|
65
|
Unfractionated heparin versus bivalirudin in patients undergoing primary percutaneous coronary intervention: a SWEDEHEART study.
|
EuroIntervention
|
2017
|
0.75
|
|
66
|
Long-term safety and efficacy of drug-eluting and bare metal stents in saphenous vein grafts.
|
Am Heart J
|
2012
|
0.75
|
|
67
|
Long-term results following switch from abciximab to eptifibatide during percutaneous coronary intervention.
|
Clin Cardiol
|
2010
|
0.75
|
|
68
|
Consideration of the total ST-segment deviation on the initial electrocardiogram for predicting final acute posterior myocardial infarct size in patients with maximum ST-segment deviation as depression in leads V1 through V3. A FRISC II substudy.
|
J Electrocardiol
|
2005
|
0.75
|